Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients? Source: Eur Respir J 2006; 28: Suppl. 50, 389s Year: 2006
Optimal cut-off point of exhaled carbon monoxide to validate self-reported smoking status in healthy adults Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011
The importance of measuriing exhaled carbon monoxide in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003
Correlations between lung function, exhaled carbon monoxide and „lung age” in smokers versus former smokers with COPD Source: International Congress 2017 – Smoking and health hazards Year: 2017
Smoking and exhaled NO concentration in patients with COPD Source: Annual Congress 2010 - COPD: diagnosis Year: 2010
Cut-off levels for exhaled carbon monoxide in smoking cessation program Source: Eur Respir J 2006; 28: Suppl. 50, 389s Year: 2006
Exhaled carbon monoxide according to daily cigarette consumption in healthy smokers Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions Year: 2011
Increase of exhaled carbon monoxide in subjects with non-controlled asthma Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
Exhaled carbon monoxide and degree of dependency in smokers attending an antismoking center Source: Annual Congress 2007 - Smoking cessation Year: 2007
Exhaled carbon monoxide in childhood asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Factors affecting exhaled carbon monoxide measurement as a biomarker of smoking Source: Annual Congress 2010 - Epidemiological data for smoking control Year: 2010
Effects of water-pipe (narghile) smoking on exhaled carbon monoxide levels Source: Annual Congress 2009 - Tobacco: from smoke to disease Year: 2009
Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002
Measurement of urinary cotinine and exhaled air carbon monoxide levels among active, passive smoker and non-smoker health staff Source: Eur Respir J 2006; 28: Suppl. 50, 470s Year: 2006
Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012
Exhaled carbon monoxide in asthma: a prospective study Source: Eur Respir J 2003; 22: Suppl. 45, 413s Year: 2003
Efficacy of assessing carbon monoxide in a smoking cessation programme for patients with pulmonary disorders Source: Eur Respir J 2002; 20: Suppl. 38, 134s Year: 2002
Association of childhood asthma and smoking with FEV1, bronchial reactivity and exhaled nitric oxide in young men with current symptomatic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 681s Year: 2004
Exhaled carbon monoxide levels during treatment of acute asthma Source: Eur Respir J 2001; 17: 1336 Year: 2001
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016